Articles tagged with Depression
A systematic review found that creatine monohydrate may reduce depressive symptoms in people taking standard antidepressants, with two trials showing significant benefits. However, three trials showed no effect, and the evidence is not yet settled due to limitations such as small sample sizes and biased patient enrollment.
Researchers at University of Toyama found three risk factors for mother-infant bonding disorders: difficulty holding a fussy baby, low happiness about pregnancy, and lack of social support. These factors predict increased risks of developmental delays and child abuse.
A new study suggests that functional brain imaging can help guide accelerated transcranial magnetic stimulation (TMS) for depression, leading to improved symptoms and response rates. The approach uses resting-state functional connectivity analysis to identify individualized treatment targets.
Most adults in Singapore living with anxiety or depression are open to receiving support from peers, even if they haven't sought professional help. Peer support is identified as a potentially important complement to existing healthcare infrastructure, offering a community-based pathway to encourage more people to seek help earlier.
A study published in Psychological Medicine found that a laxative drug, Prucalopride, improved executive function and memory in patients with depression. The research suggests that targeting serotonin receptors may help alleviate cognitive problems associated with depression.
Researchers found that pramipexole, a Parkinson's disease medication, improved symptoms of anhedonia in patients with treatment-resistant depression. The therapy was associated with positive effects on the brain's reward system and increased physical activity.
Researchers identified distinct brain activity patterns in people with depression, which may contribute to the experience of feeling stuck. The study suggests depression involves a form of brain-state entrapment, where the brain becomes more likely to enter certain patterns of activity and less likely to transition out of them.
A new study by UC San Francisco found that women with HIV are more likely to die from preventable trauma-related conditions like substance use and mental illness. The researchers say these causes are largely missing from official death records, highlighting the need for broader goals in HIV care beyond just controlling the virus.
Adolescents who spend at least two hours a day on social media are more likely to experience depressive symptoms and poorer wellbeing, with the strongest effects seen in girls aged 12–13 years. The study, which followed almost 1,200 children from age nine to 19, highlights the need for policies that reduce excessive screentime.
A study published in Cell Host & Microbe suggests that GLP-1 analogs may alleviate depression in mice by modulating the gut microbiome. The researchers found that a specific microbe strain, Lactobacillus delbrueckii, played a key role in this process.
Childhood maltreatment alters fear-related brain function and systemic inflammation, modulating their connection. The timing and type of abuse or neglect shape this link, with early trauma affecting threat-regional brain areas and late trauma impacting regulatory brain regions.
A pilot study by Penn State researchers found that wearing a cooling cap for 30 minutes can improve a person's sense of well-being and reduce depressive symptoms. The study also showed an increase in alpha brain waves, indicating a calming effect.
A new study has uncovered how antidepressants affect different groups of serotonin-producing brain cells in opposite ways. Researchers found two distinct subpopulations of neurons that respond differently to SSRIs, mirroring the clinical picture where unpleasant effects come first and relief comes later.
A cohort study found that smartphone acquisition at age 13 was linked to increased risk of insufficient sleep at age 14. Excessive smartphone use was also tied to higher odds of depression and obesity. Limiting screen time may protect adolescents from these outcomes.
The FUTURE-D project combines data science with clinical expertise to identify warning signs of depression earlier, enabling more targeted interventions. Researchers will integrate longitudinal cohort data from the MACS and NESDA studies to better understand depressive disorders.
A new framework, criticome, integrates experience until age 25, reframing autism, schizophrenia, depression, and trauma as developmental disorders. The study suggests that screen-saturated childhoods may produce adult dysfunction, highlighting the importance of early experience in brain development.
Deep brain stimulation (DBS) can remodel white matter pathways in the brain and alter communication across large-scale neural networks. The therapy helps patients recover from severe depression by increasing fractional anisotropy and myelination within specific pathways, suggesting a previously unrecognized mechanism.
A new book by a Cambridge child psychotherapist argues that treating parents alongside children is crucial for addressing the youth mental health crisis. The author highlights the importance of considering an 'ecological system', including families, communities, and environment, in understanding young people's wellbeing.
Researchers found biomarkers for Alzheimer's disease that correlated with minor cognitive differences in midlife adults. These biomarkers, measuring tau and amyloid plaque, were associated with a greater chance of cognitive decline, particularly in processing speed and executive function.
A new preclinical study finds that estrogen loss in the extracellular matrix of the hippocampus may contribute to memory decline and increased risk of Alzheimer's disease in postmenopausal women. The study suggests a possible new treatment approach focused on restoring the brain's supportive environment.
A new study by the University of Ottawa suggests that a tiny molecule, methylglyoxal, plays a major role in triggering neurological disorders after a heart attack. The molecule accumulates in the brain following a heart attack and is linked to depression, anxiety, and cognitive decline.
A machine-learning guided lifestyle coaching program based on data collected via personal devices reduced depressive symptoms by six weeks. Participants who implemented the program experienced significant reductions in depressive symptoms and the treatment effect persisted during three months after the intervention ended.
Researchers linked duration and severity of depression to differences in functional brain connections, paving the way for personalized treatments. Changes in brain networks, particularly the Central Executive Network and Default Mode Network, were associated with varying degrees of depressive symptoms.
The study found that mental disorders disproportionately affect young people aged 15-19 and women, with anxiety and depression ranking among the top causes of disability globally. Mental disorders now account for 171 million DALYs, placing them as the fifth-leading cause of total disease burden worldwide.
Interleukin 6 is investigated as a treatment target for depression in this randomized clinical trial. The study highlights the therapeutic potential of IL-6 or IL-6 receptor inhibition and proposes suitable patient selection methods.
A University of Bristol-led pilot trial found that tocilizumab reduced symptoms of depression, fatigue and anxiety in people who had not responded to standard treatments. The study provides early evidence for a new treatment option for patients with inflammation-related depression.
A longitudinal study identified distinct brain-wave patterns emerging from age 9 that can forecast a child's vulnerability to anxiety or depression by age 13. The predictive markers reveal divergent neurodevelopmental trajectories linked to the right and left sides of the brain, respectively.
A low-cost game that can identify patients with depression in just three minutes has been developed by NYU Langone Health researchers. The game uses neurobiological studies to measure how patients' decisional reference points respond to changes in their environment, providing clues about what is happening in their brains.
A new study finds that individuals with higher resilience tend to place greater weight on positive aspects in cost-benefit decisions, a process mediated by brain activity. This regulated handling of negative information is linked to increased acceptance and improved psychological resilience.
Researchers found that individuals with stronger brain responses to negative information were more resilient in their thoughts and feelings. They accepted more offers with mixed consequences, indicating a lower value on negative outcomes. This study suggests that controlling negative thoughts may enable people to build mental resilience.
A study links insulin resistance and leptin dysregulation to cognitive impairment in bipolar disorder, highlighting the potential of targeted clinical pathways. Metabolic alterations are associated with cognitive deficits and poorer performance in memory and attention.
Researchers discovered that genes linked to neuronal communication are also altered in immune cells of patients with depression, reinforcing the systemic nature of the disease. This finding paves the way for developing blood tests to identify and diagnose depression, as well as new treatment approaches targeting inflammation.
A digital therapy app was found to be more effective in treating anxiety disorders, depression, and eating disorders among college students compared to traditional campus clinics. The study, which tested the app's effectiveness over six months, showed a significant increase in symptom-free students and services uptake.
A randomized clinical trial found that genotype-guided prescribing of SSRIs did not improve depression symptoms at 3 months but showed higher remission rates at 6 months. Future studies should focus on the long-term impact of this approach.
This systematic review and meta-analysis found differences in efficacy and acceptability of adjunctive atypical antipsychotics for major depressive disorder. The study highlights the need for more well-controlled studies on maintenance efficacy of these medications.
A systematic review and meta-analysis found single and repeated intravenous ketamine infusions to be efficacious in reducing suicidal and depressive symptoms in acute major depressive episodes. Longer-term outcomes remain unclear.
A new study with over 3,700 UK participants found that better cognitive functioning may be associated with a higher risk of future depressive episodes in those with a history of depression. In contrast, worse cognitive performance was linked to a lower risk of relapse in both individuals with previous depression and control participants.
Researchers found that psilocybin causes temporary shifts in brain entropy, leading to increased insight and emotional self-awareness. This correlates with improved well-being and cognitive flexibility, suggesting the psychedelic trip is key to its therapeutic effects.
Researchers developed a framework to study the impact of genetic variants on neurodevelopmental disorders. By analyzing induced pluripotent stem cells, they found that genetic background can lead to different clinical outcomes in individuals with the same deletion on chromosome 16.
Researchers found that accelerated biological aging of a type of white blood cell called monocytes is linked to cognitive and mood-related symptoms of depression. This discovery could lead to earlier diagnosis and personalized treatment for depression, particularly in high-risk populations such as women with HIV.
Researchers identified a specific subset of opioid receptors on interneurons in the prefrontal cortex that ketamine targets to relieve depressive symptoms. Combining small doses of three drugs targeting the same pathway may provide an effective alternative to ketamine with fewer side effects.
A study by SWPS University found that people with depressive symptoms use less active language, such as 'I am incapable' instead of 'I achieve goals'. This analysis of social media posts shows promise for early detection and prevention of depression.
A nationwide ecological study found a statistical correlation between fewer psychiatric beds and higher suicide rates in Sweden. The study suggests that investing in outpatient care may not be enough to prevent suicides, highlighting the need for further research into healthcare resource allocation.
Dampening, a phenomenon where positive emotions are diminished, can undermine well-being over time. Research found that future-focused thoughts, such as 'positive feelings won't last,' are strong predictors of depressive symptoms.
Motif Neurotech has received FDA approval to begin the first clinical trial of its therapeutic BCI device, DOT, for treatment-resistant depression. The study will test the device's effectiveness in delivering electrical stimulation to brain circuits linked to depression.
Researchers at Rutgers University tested the efficacy of Bright IDEAS, a problem-solving skills training intervention, in reducing depression and anxiety symptoms and improving health-related quality of life among young adults with cancer. The study found significant reductions in symptoms and improvements in quality of life compared t...
New research suggests exposure to fathers' depression in pre-adolescence is associated with poor educational outcomes among males, but not females. Early identification and family-centered support can help promote school success and long-term well-being for affected sons.
A study published in Scientific Reports reveals a connection between ADHD-related traits and chronic pain, highlighting the importance of addressing ADHD in pain management. The research suggests that treating ADHD may help reduce chronic pain severity.
A new study reveals that electroconvulsive therapy (ECT) can lead to significant negative impacts on standard of living, personal relationships, and even brain damage. Relatives and friends of ECT patients report long-term effects including memory loss, emotional blunting, and loss of independence.
A recent study estimates that 2.8% of US residents over 12 used psilocybin in the past year, highlighting the need for clinicians to be aware of its use among patients with depression. The findings also underscore the importance of longitudinal studies and increased public health surveillance as de-criminalization efforts progress.